Meet With Industry

Agendia is a precision oncology company committed to improving clinical outcomes and informing the journey for patients with early stage breast cancer. Through its state-of-the-art laboratory, the company currently offers two commercially-available genomic profiling tests. MammaPrint®, the 70-gene breast cancer recurrence assay, is the only FDA-cleared risk of recurrence test backed by peer-reviewed, prospective outcome data and inclusion in both national and international treatment guidelines. BluePrint®, the 80-gene molecular subtyping assay, is the only commercially-available test that evaluates the underlying biology of a tumor to determine what is driving its growth. Together, MammaPrint® and BluePrint® provide a comprehensive genomic profile to help physicians make more informed decisions in the pre- and post-operative treatment settings. By developing evidence-based novel genomic tests, Agendia aims to support the evolving clinical needs of breast cancer patients and their physicians. Agendia’s assays can be ordered on core biopsies or surgical specimens with results in as little as 5-7 days to inform pre- and post-operative treatment decisions. For more information on our assays and our on-going trials, please visit www.agendia.com

American Breast Care offers a complete range of post-breast surgery products. From high quality, comfortable breast forms, to functional and fashionable bras to post-surgery and leisure products, ABC has the products you and your patients need.

Applied Medical designs, develops, manufactures and sterilizes healthcare solutions that enable advanced surgical procedures and optimize patient outcomes. We achieve this while also reducing healthcare costs and offering unrestricted choice. Applied Medical is committed to furthering minimally invasive surgery by offering sophisticated training, including workshops, symposia and our simulation-based programs.

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory & Immunology. For more information, please visit www.astrazeneca-us.com and follow us on Twitter @AstraZenecaUS.

bcalmed, Inc., a 501(c)(3) non-profit, and the bcalmed bag were created to help patients manage post-operative drains after surgical procedures such as mastectomies and lumpectomies. The bcalmed bag is provided free of charge to any patient to ease their journey to recovery.

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. bd.com

For more than 40 years, Best Medical has served the medical community with the highest quality products and unparalleled customer service. Our brachytherapy seeds, gold fiducial markers, supplies, accessories and exam equipment exemplify our commitment to uncompromised quality and safety. Best Medical International now encompasses a family of trusted companies and organizations with a proven track record of innovation, quality and service in external beam radiation therapy, brachytherapy and vascular brachytherapy solutions. Our aim is to be the one partner that clinicians turn to for all their radiotherapy and oncology product and service requirements.

Blackwell bra was developed to create garments to enhance recovery and comfort after surgery.

Boiron, world leader in homeopathic medicines, is best known for its popular Arnicare® line of pain relievers and Oscillococcinum® flu medicine. Founded in 1932 by Jean and Henri Boiron, the company provides a full line of low-risk options to benefit consumers and health care professionals in more than 50 countries.

C2Dx is a medical device company that acquires and invests in underserved products to propel their impact worldwide. Founded in early 2019 by industry experts, C2Dx is committed to providing leading medical products and superior customer service while continually evolving to ensure that healthcare providers have the devices and technology they need.

Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The Nuclear & Precision Health Solutions division is committed to improving the lives of patients by applying more than 40 years of experience and expertise in nuclear and precision health. The business provides radiopharmaceutical development, manufacturing, preparation, market access, and business solutions across the care delivery continuum from origin to patient administration. As the only national source for both SPECT and PET radiopharmaceuticals with the largest network of 130 pharmacies and 30 cyclotron facilities, we can reach 95% of U.S. hospitals within three hours. We give customers the support they need in regulatory compliance, reimbursement, continuing education, information management and other crucial areas, so they can focus on their patients. Discover how collaborating with us can help you achieve high-quality patient care, operational efficiency and market leadership. Learn more at cardinalhealth.com/nps.

Southern Scientific has many years of experience and expertise working in the specialist health sector. Indeed, as part of the LabLogic group, the company is a key supplier to the healthcare sector worldwide. We are the manufacturer of the Care Wise C-Trak Apollo Gamma Probe System which provides accurate and precise detection of radiation for use during sentinel node biopsies in breast, melanoma and other types of cancer. The C-Trak Apollo’s distinctive feature is our superior sensitivity and directionality, but now we also offer wired or wireless connectivity with the same probe allowing for complete flexibility. Using our proven OmniProbe® technology, the Apollo offers precise and accurate detection of various isotopes. Its superior directionality means quick and accurate identification of subjects which leads to less dissection and improved procedures. Software for the C-Trak Apollo has been reimagined, with several new features including autoranging capabilities, choice of four audible signals, easier switching between isotopes (such as Tc-99m and I-125), storage of calibration tests and prompts for renewing calibration sources.

Cirdan is a leading provider of informatics and imaging solutions that support and speed up patient diagnosis. Headquartered in the UK, with offices in Canada and Australia, Cirdan is recognised as one of the leading suppliers of laboratory information systems (LIS) worldwide. Our products include ULTRA, a LIS that supports and streamlines the operations of a clinical laboratory, and the CoreLite and Solas-OR x-ray systems which expedite breast cancer diagnosis. We also offer Tutor, a digital pathology education platform, and software solutions that support artificial intelligence and machine learning in digital pathology technologies. Innovation is at the heart of Cirdan, and we are committed to improving the treatment of breast cancer and helping surgeons reduce readmission rates by providing rapid and accurate imaging at the point of care for both core biopsy and surgical specimens. CoreLite is our dedicated specimen x-ray cabinet designed to verify microcalcifications of breast biopsy cores. It is compact and self-contained cabinet, meaning it can be located in the biopsy room where specimens can be imaged and verified in seconds at the point of care, allowing for a significantly shorter procedure, which reduces patient anxiety and stress. Solas OR is our dedicated X-ray specimen cabinet designed for surgical and biopsy suites, providing high image quality, streamlined workflow and reduced procedure times. Enabling clinical staff and surgeons to accurately and securely manage patient cases as efficiently as possible. Find out more at www.cirdan.com.

Image Clarity You Can Trust for OB/GYN. Ultra-portable and affordable, Clarius HD3 handheld ultrasound is the ideal system for rapid exams to improve efficiency in your busy OB/GYN practice. Quickly confirm fetal viability, placental and fetal position, and asses amniotic fluid. The new Advanced OB/GYN Package features comprehensive biometric measurements and reporting, and new labor and delivery tools.

Clarix Imaging brings unprecedented clarity to intraoperative lumpectomy margin visualization with our true 3D (CT) VSI-360™ Volumetric Specimen Imaging System. This advanced imaging technology takes breast surgeons and radiologists on a Journey Through the Specimen with views of any tissue slice from multiple angles – with no obscuring of the margins. A venture-backed private company founded by world-renowned medical imaging scientists from the University of Chicago, Clarix Imaging’s mission is to empower clinicians with clear tumor visualization and intelligent analysis for precision and personalized medicine based on breakthrough innovations in imaging science and AI. Our first product is the FDA cleared true 3D VSI-360™, which offers radiologists and surgeons unprecedented clarity for intraoperative specimen margin visualization in breast cancer surgeries such as lumpectomy – right inside the operating room. VSI-360™ generates a true 3D image of the specimen in real-time, and its advanced software tools allow users to visualize the tumor in thin image slices without overlapping tissues obscuring the margins. Partner with us on our journey to advance outcomes in surgical oncology through innovations in imaging.

Designs for Vision, Inc. was established in 1961 to enhance the visualization of clinical professionals through wearable magnification and illumination devices. The mission has expanded into the field of Fluorescence Guided Surgery, with the REVEAL FGS. We are lowing the capital expense to provide FGS and making FGS available to all medical centers

Diagnostic Robotics is a leading provider of fully integrated population health management, triage, and navigation solutions. These AI and rules-based solutions, which are trained on tens of billions of claims data points and nearly 100 million patient visits, integrate seamlessly into major touchpoints along the patient journey, and provide high-value decision support while slashing administrative burdens, massively reducing cost of care, and improving patient experiences.

Dilon Technologies® Inc. is a medical device manufacturer that benefit patients with: Lymphatic mapping via gamma probe, Real-time margin assessment with MarginProbe, a specimen analyzer with TrueView, and advanced hemostasis with Hemoblast. Our diverse product suite addresses a variety of breast cancer surgical needs impacting positive patient outcomes.

Elucent Medical has designed the EnVisio™ Navigation System; a novel device that utilizes an innovative electromagnetic field and SmartClip™ to enable precise stereotactic navigation within a wide field of view to a target of interest. The integration of the navigation tool onto the electrocautery device provides real-time guidance in the surgical field to deliver visual and audible indicators that provide Depth, Distance, and Direction to the SmartClip. This integrated system enables increased speed because of the ability to have the EM pad providing localization of SmartClips, in addition to the Real-Time Navigation is within the surgeon's hand. The guidance and localization update as the tissue is manipulated during the surgery. The generation of an unprecedentedly large field of the electromagnetic field for navigation, the EnVisio System, and SmartClip technology broaden the treatable patient population expanding SmartClip localization from the breast, and lymph nodes to the head and neck, abdominal soft tissue as well as the lung in the future. Elucent Medical is founded on the continued collaboration of multi-disciplinary physicians who seek to improve patient outcomes. The EnVisio Navigation system addresses the clinical need to meet the broadest patient demographics from simple (single site) to complex (several sites in the breast and axilla) cases allowing individualized treatment.

Everyone deserves a better standard of cancer care.

Everyone deserves a better standard of cancer care.

Esaote North America, Indianapolis, part of the Esaote Group, a global leader in research, production and marketing diagnostic medical equipment. Among the largest manufacturers of ultrasound systems worldwide, Esaote prides itself in achieving superior price and performance. Esaote delivers a wide range of ultrasound Imaging solutions in main women's health imaging applications from light-weight portable laptops to premium performance cart-based systems.

Exact Sciences Corporation A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its product pipeline with the launch of the OncoExTra and Riskguard tests to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.

Hologic is a global medical technology company specializing in women’s health and well-being. We offer innovative solutions for screening, detecting and treating conditions and diseases that affect women throughout their lives, including breast, gynecological and skeletal issues; cervical cancer testing; and sexually transmitted diseases. As a science-driven company, our products are backed by clinical evidence, ensuring that they perform as intended, so healthcare professionals can have greater certainty in their decisions and patients, greater peace of mind.

IceCure Medical is setting new standards in minimally invasive cryotherapy for women’s health and interventional oncology. Our FDA-cleared and CE-marked ProSense® Cryoablation System utilizes the power of liquid nitrogen to destroy tumors by freezing them to ultra-low temperatures for optimal tumor destruction. For women with breast tumors, the ProSense® System provides patients with a safe, fast, in-office cryoablation procedure with excellent cosmetic results. ProSense® has received FDA clearance for the treatment fibroadenomas and in 2021 was granted FDA Breakthrough Device Designation for the treatment of patients with T1 invasive breast cancer and/or patients not suitable for surgical alternatives for the treatment of breast cancer. IceCure is conducting the ICE3 Clinical Trial, the largest multi-center trial for cryoablation of small, low-risk breast cancer. The latest interim analysis shows promising results with 96.91% of patients who are recurrence free.

ImpediMed is a medical technology company that uses bioimpedance spectroscopy (BIS) technology to generate powerful data to maximize patient health. The SOZO® Digital Health Platform, the world's most advanced, noninvasive BIS device, delivers a precise snapshot of fluid status and tissue composition for lymphedema assessment - all in less than 30 seconds. Early detection and intervention of lymphedema at the subclinical level before any visible swelling is critical. Offer your patients peace of mind. Know their L-Dex® score with the leading technology for point-of-care lymphedema assessment. Learn more: www.impedimed.com

INRAD is a developer and manufacturer of specialty medical products for biopsy and interventional procedures.

Invitae’s mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Our goal is to aggregate the world’s genetic tests into a single service with higher quality, faster turnaround time and lower prices. Visit www.invitae.com.

Irrimax Corporation is a medical device company located in Lawrenceville, GA, serving customers in all 50 states and is doing business in Brazil, Canada, Chile, Mexico, Panama, Saudi Arabia, and other countries. Irrimax focuses on reducing infections, healthcare costs and improving patient outcomes. Irrisept Antimicrobial Wound Lavage, the company’s flagship product, has been adopted, in the US alone, by over 3,000 hospitals and sold over 3,000,000 units. Irrisept is considered essential, as part of a best-in-class infection prevention protocol for hospitals. Irrimax is consistently ranked among the highest in its peer group in product quality, service levels, and customer support.

IsoAid manufactures Advantage® I-125 low-energy seeds for Radioactive Seed Localization(RSL). Our seeds have been successfully used as an alternative to wire localization for 12 years, while this method has been successfully being performed for over 18 years. Seeds are more comfortable for the patient, offer less chance of infection and can be placed up to 5 days before surgery. To perform a RSL you won’t need any additional skills you aren’t already using to place and remove clips and there are no start-up costs. We make the switch easy for you with our team of experts that are dedicated to helping with your program, including being a complete resource for you. We offer easy online ordering and deliver custom made seeds to you in one of 3 needle sizes, sterile and ready to use. IsoAid’s innovative Secure Strand® technology allows us to provide a material over the seeds that ensures the seeds stay where they are placed, even after compression. We also provide an easy to use disposal and return kit, as well as a decay chart that calculates the activity of the seeds on any day within the 180 days that they are sterilization valid. At IsoAid we are committed to helping you treat your breast cancer patients and we look forward to showing you our new advances very soon. Please stop by our booth and allow us to introduce you to our RSL product.

iSono Health's mission is accessible and personalized breast imaging for every woman everywhere. iSono's first product that is FDA cleared is a first -of-its-kind wearable and automated 3D whole breast ultrasound

At KUBTEC®, our passion is developing transformative specimen imaging, breast cancer margin management, and specimen radiography systems that enable medical professionals to provide the best quality of care for their patients. Our proprietary award-winning technologies, such as 3D breast specimen tomosynthesis; advanced, high-resolution specimen X-ray imaging; and intelligent workflow management features, are redefining specimen radiography and breast cancer surgery standards for the 21st century.

Lumicell is a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery. The company’s first investigational product is the Lumicell Direct Visualization System (DVS), designed to enable real-time assessment of the breast cavity, by aiding in the detection and resection of residual cancer that may have otherwise been left behind after the main specimen has been removed. The Lumicell DVS features a handheld intra cavity imaging probe and a patient calibrated cancer detection software designed to work in conjunction with LUMISIGHT, a proprietary optical imaging agent, to illuminate residual cancer undetected by standard-of-care. LUMISIGHT is also being explored across a wide variety of solid tumor indications. For more information, please visit www.lumicell.com.

We believe compassion should lead innovation, and our vision is to be the definitive ally in breast care. With patients at the center of all that we do, we develop technologies that empower clinicians, physicians and surgeons to support and guide patients along their breast care journey.

Maple Tree Cancer Alliance is a non-profit organization that partners with cancer centers to provide supervised, individualized exercise programming to patients in active treatment.

About Masthead Masthead® was launched in 2012 by a physician who was also a mastectomy patient. Her personal and professional experience gave her the most intimate knowledge of the challenges post-op recovery can present, enabling her to create solutions that are second to none. Owned by women with decades of experience in medicine, design, and performance materials, Masthead provides state-of-the-art products and exceptional customer service at every step of your patients’ journeys. The top hospitals in the country provide our innovative flagship Elizabeth Pink Surgical Bra®— to their patients. By listening to and working with leading clinicians in the field from all over the world, we’ve been able to continuously update current products and design important new ones to meet the evolving surgical techniques and clinical trends. We at Masthead® have guided hundreds of thousands of women from diagnosis through recovery. Helping you provide the best care to your patients is our mission.

We lead global healthcare technology. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people. Transforming the lives of two people every second, every hour, every day. Medtronic. Engineering the extraordinary.

At Merck, our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer. The potential to bring new hope to people with cancer drives our purpose and our commitment. As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry across more than 30 tumor types.

Merit Oncology is on a mission to reduce the burden cancer places on patients and their loved ones. As a provider of world class solutions for the diagnosis, localization, and treatment of cancer, Merit Oncology consistently invests in improving our technologies and innovating new platforms to meet our physicians' needs. The preferred localization solution to treat more patients, the SCOUT® Radar Localization system has been clinically proven in over 385,000 breast and soft tissue localizations and is referenced in over 75 clinical publications. The technology represents unparalleled accuracy, can be placed under all imaging modalities, and will not interfere with imaging interpretation, including MRI. It is uniquely suited to be placed at any time prior to surgery, including prior to neoadjuvant chemotherapy. The SCOUT system has been clinically demonstrated to improve patient outcomes, workflow and significantly reduce OR delays. Easing the burden of breast cancer treatment, SAVI® Brachy offers a strut-based approach to tissue-sparing dosimetry and is designed to maximize ease of use during placement while providing unparalleled dose customization. Three-fraction treatment protocol with SAVI allows effective APBI treatment to be completed in as little as 2 days, sparing healthy tissue and significantly reducing patient treatment time.

MOLLI Surgical started in the operating room, where surgeons were using dated tools to treat breast cancer patients — and we knew we could do better. Our localization system is precise, easy to use and built with the realities of the operating room in mind. More importantly, it is built with patients in mind. MOLLI® is designed to help surgeons remove lesions more efficiently with increased patient comfort. By utilizing the latest advancements in magnetic technology to localize with accuracy and specificity, MOLLI delivers a better patient experience than traditional wire and other localization options. It’s efficient and designed to work with standard clinical workflows. MOLLI is reliable and can be used with standard metal instruments and electrocautery. In addition to the MOLLI technology, our team is actively developing programs to support your practice and operations, such as dedicated onsite support to improve OR efficiency. Our certified clinical operations experts will work with you and your teams to improve clinical workflows and operations. We provide patient education support to help increase patient awareness and engagement in breast cancer care. To help amplify awareness and outreach to patients, our marketing and PR experts can develop campaigns to promote physicians and health care providers who are advancing the field of breast cancer. We look beyond building products to help healthcare get simpler to get better. Together we can reach more patients so they can access the screening and treatment options that are right for them.

Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad discovers and commercializes genetic tests that determine the risk of developing disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where critical genetic insights can significantly improve patient care and lower healthcare costs. Fast Company named Myriad among the World’s Most Innovative Companies for 2022. For more information, visit www.myriad.com.

Natera has developed Signatera, a personalized ctDNA test for molecular residual disease (MRD) detection, recurrence and treatment response monitoring in patients previously diagnosed with cancer. Signatera's tumor-informed assay is optimized to detect low levels of ctDNA, with high accuracy in identifying MRD and recurrence earlier than standard tools. Signatera has been clinically validated in multiple cancer types including colorectal, non-small cell lung, breast, and bladder cancers. The test is available for clinical and research to help monitor breast cancer and inform critical decisions for care. Learn more at http://www.natera.com/signatera-breastcancer-clinicians.

NeoDynamics, Inc. is committed to developing innovative solutions to improve patient care with the introduction of NeoNavia®, an ultrasound-guided, minimally invasive, precision biopsy system based on patented pulse technology designed to allow large, high-quality tissue samples to be taken from technically difficult lesions as well as locations generally considered to be difficult to access.

Not Putting on a Shirt (NPOAS) is a patient-led, all-volunteer 501(c)(3) nonprofit organization advocating for optimal aesthetic flat closure for women who choose to go flat after mastectomy. NPOAS provides education, tools, and peer support to empower patients and educate medical providers, supports research on AFC, and conducts institutional advocacy to improve outcomes for patients.

obp is the leading global developer of single-use, self-contained, illuminating surgical devices. We integrate light with device — making them one — creating effective and simplified single-use solutions. Our innovative products are used in surgery centers and hospitals throughout the U.S., as well as healthcare facilities worldwide.

OSF HealthCare is an integrated health system owned and operated by The Sisters of the Third Order of St. Francis in Peoria, Illinois. Recognized as one of the top healthcare employers in the United States, we employ more than 22,000 Mission Partners in 156 locations throughout Illinois and Michigan, including nine system wide service lines and two colleges of nursing.

Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesia approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. To learn more about Pacira, visit www.pacira.com.

Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools that address unmet medical needs. Based in Toronto, with U.S. headquarters in Dallas, Texas, Perimeter aims to harness the power of big data, artificial intelligence, and machine learning technology to further its mission of improving the standard of care, providing better long-term outcomes for patients, and reducing healthcare costs. Available now across the U.S., Perimeter’s S-Series OCT, powered by Optical Coherence Tomography, is designed to visualize tissues at the cellular level during surgical procedures, rather than days later when pathology reports come back. Our FDA-cleared technology gives surgeons cross-sectional visualization of surgical margins and excised tissues in real time, with 10x higher image resolution than standard X-ray and ultrasound, and 100x greater than MRI. Our next-generation technology will use ImgAssist AI, a powerful artificial intelligence and machine learning tool designed to assist surgeons with visualizing margins. In November 2021, Perimeter received FDA Investigational Device Exemption (IDE) approval and launched a multi-site, randomized clinical trial using Perimeter B-Series OCT with ImgAssist AI. The study evaluates this system against the current standard of care and assesses the impact on re-operation rates for patients undergoing breast conservation surgery. For more information, visit www.perimetermed.com

PreludeDx is the leading personalized breast cancer diagnostics company dedicated to improving outcomes or patients diagnosed with DCIS (Ductal Carcinoma in Situ). The company provides patients and physicians with evidence-based tools to improve patient outcomes and reduce the cost to the healthcare system by helping to ensure women are not over or under treated. For women diagnosed with DCIS, PreludeDx provides a patented molecular test (DCISionRT®) that predicts a woman’s personal likelihood or risk of developing DCIS recurrence in 10 years and invasive breast cancer in 10 years with or without adjuvant radiation therapy after breast conserving surgery. Visit PreludeDx.com

The Premier Surgical Network is seeking breast surgeons (Fellowship trained, General Surgeons with Breast Accreditation, Surgical Oncologists with Breast emphasis – community-based) to join its growing multi-specialty group in the tri-state area. The ideal candidate should have a good clinical foundation in breast care/breast surgery and is interested in developing a private practice in NJ, NY, or PA. We currently have 31 offices to complement a successful breast practice.

Axogen has over 10 years of experience as a leader in surgical solutions for peripheral nerve repair. Our products are used primarily by reconstructive plastic surgeons, hand surgeons, and oral and maxillofacial surgeons in a wide variety of nerve repair surgeries.

Ronin Surgical Corp. -- makers of the X6 Surgical Headlight System. The wireless X6 is the lightest, brightest, longest-running operating room surgical headlight on the market. Contact Ronin Surgical at +1.415.226.9414 or Contact@RoninSurgical.com. Ronin Surgical: Designed Without Compromise. www.RoninSurgical.com

SBI ALApharma Canada Inc. is a Toronto-based medical imaging company that is expanding the clinical translation and applications of its proprietary handheld imaging technology in conjunction with 5-ALA to improve the outcomes and lives of cancer patients with surgical needs. Approximately 1 in 5 women still require a second surgery, following their index breast conserving surgery, in order to achieve clean surgical margins. SBI ALApharma Canada Inc. recognizes this un-met need. It is our mission to address this requirement in care - by providing breast cancer surgeons with the ability to visualize residual disease in real-time during index breast cancer surgeries. Driven by this mission, SBI ALApharma Canada Inc. is conducting a pivotal Phase III clinical trial to assess the use of fluorescence-guided surgery for breast cancer patients. This clinical trial will collect data on the use of PD G 506 A (investigational drug) and the handheld fluorescence camera (investigational device) to evaluate intra-operative real-time fluorescent visualization of cancer during breast lumpectomy surgeries. Established in August 2019, SBI ALApharma Canada Inc. is a 100% subsidiary of photonamic (Germany). Our trial details can be viewed in full here: https://clinicaltrials.gov/ct2/show/NCT04815083

The SDM Adoption and Implementation Resource (SHAIR) Collaborative is an online learning collaborative platform for breast cancer teams across North America. The SHAIR Collaborative goal is to improve shared decision making in early-stage breast cancer care by utilizing conversation aids. The SHAIR Collaborative provides (1) free access to conversation aids for surgical treatment of early-stage breast cancer in multiple languages, (2) regular live online webinars, (3) integration guides, (4) individualized implementation guidance, (4) training videos, (5) discussion forum, and (6) patient feedback dashboard. The SHAIR Collaborative is led by Professor Glyn Elwyn at Dartmouth College and Dr. Julie Margenthaler at Washington University in St. Louis.

Silbiotech featuring the BBDRisk Dx® Test. The BBDRisk Dx® Test (Benign Breast Disease Risk Diagnosis) is a new tumor biology based genomic test designed to address the dilemma in treating atypical hyperplasias. Studies show that ~20% of atypical patients develop cancer. The BBDRisk Dx® Test assesses multiple cancer markers in FFPE atypical tissues by IHC, generates a ‘Risk Score’ from 0-10 and categorizes the patient into a Low, Intermediate or High Risk group. Cancer rates in the low risk group are less than 3% over 15 years. Cancer rates in the high risk group are 75% in the first five years after atypia diagnosis. In the intermediate group cancer rates are less than 20% over 15 years. BBDRisk Dx® was validated in 550 clinical samples. BBDRisk Dx® offers for the first time assessment of a patient’s personalized risk level. Clinicians can now make informed treatment decisions in managing atypias.

SimBioSys, Inc. TumorSight: Surgical and Treatment Guidance Technology. Precision Oncology using applied biophysical modeling and artificial intelligence on medical imaging of solid tumors.

With its roots in the Netherlands Cancer Institute, Sirius Medical is dedicated to improving care for cancer patients by delivery of unsurpassed, yet affordable solutions to help physicians and hospitals manage growth and control costs. The Pintuition® surgical marker navigation system, powered by GPSDetect™ is CE marked and FDA 510(k) cleared. The system utilizes a unique multi-sensor probe that provides real-time distance and direction using audio and visual feedback for unmatched precision to locate tumors easily and accurately. Sirius Medical has an experienced and dedicated US team to support customer implementation, training and support.

Offering customized pathology services throughout the United States, Sonic Healthcare USA, Anatomic Pathology Division, is dedicated to offering personalized pathology services to help you deliver definitive diagnoses, ensure prompt treatment decisions and provide superior patient care. Our Breast Pathology program provides comprehensive sub-specialized diagnostics, prompt and clear reports, and daily case reviews, our fellowship-trained breast pathologists review over 35,000 breast FNAs, biopsies and excisions every year.

As a leader in minimally invasive surgery, Stryker offers comprehensive solutions to meet the changing needs of the high-tech operating room. Our long history of innovation and constant development in advanced imaging and OR connectivity is driven by our desire to help healthcare professionals to see and do more. Through our first-class services and technologies, we are committed to our customers and to helping them achieve the best possible surgical outcomes.

Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. We are proud to collaborate with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.

The US Oncology Network brings advanced care, cutting-edge research and nearly 1,400 oncologists to the treatment of approximately 900,000 cancer patients each year. With our shared commitment to providing evidence-based treatment to communities across the nation, we believe that together is a better way to fight.

Thompson Surgical celebrates over 55 years as a leader in exposure and the original manufacturer of the table-mounted retractor. We understand the value of exposure in surgery and are dedicated to providing innovative, high quality systems that deliver safe, versatile, and low-profile retraction. We offer unlimited customization and safe, independent retraction. The Thompson Retractor allows surgeons in multiple specialties to achieve Uncompromised Exposure.

Company Description: Vector Surgical is the global leader in tissue orientation devices that provide the most accurate designation of excised tissue margins in cancer surgery. Our devices integrate the needs of surgeons, pathologists and radiologists, providing tools that enable the highest level of care for their cancer patients. Leading hospitals and physicians are eliminating error and improving outcomes with our products: MarginMarker sterile ink kits, CorrectClips radiographic clips and the SilversteinWrap.

Videra Surgical is an oncology surgery company focused on breast cancer treatment. We strongly believe that helping radiation oncologists better identify the tumor bed is essential for the continuum of care for breast cancer patients. VeraForm is an adaptable tissue marker comprised of a radiopaque filament that provides a continuous, 3-dimensional, multi-plane and permanent mark of a tumor bed. Taking a surgeon about 2 minutes to place, VeraForm is easily viewed by the radiation oncologist under X-ray and CT/CBCT, but it does not create artifact in MRI or ultrasound, as it is completely metal-free. VeraForm is 510(k) cleared and has been placed in thousands of patients in a rapidly growing number of U.S. centers. VeraForm is designed to provide a precise depiction of the tumor bed, allowing radiation oncologists to be more targeted in the delivery of radiation, in an attempt to avoid over-radiating and possibly damaging collateral tissue and organs.

Woman's Hospital was one of the first women's specialty hospitals in the nation, and is currently one of the largest in the US. Opened in November 1968, Woman's is a private, nonprofit organization that is consistently recognized for its care of woman and infants. Woman's performs more than 8500 surgeries and 35,000 breast procedures, and reads more than 57,000 Pap screens. It is the largest delivery service in Louisiana with 8000 births annually.

The INTRABEAM® 600 from ZEISS is specifically designed to combine surgery and radiotherapy intraoperatively with individualized low-energy irradiation directly after tumor resection.